Expression of fibronectin splice variants and oncofetal glycosylated fibronectin in the synovial membranes of patients with rheumatoid arthritis and osteoarthritis

Rheumatology International

Volumn 24, Issue 1, 2004, Pages 25-33

  Kriegsmann, J ^a   Berndt, A ^b   Hansen, T ^c   Borsi, L ^d   Zardi, L ^d   Brauer R ^b   Petrow, P K ^b   Otto, M ^a   Kirkpatrick, C J ^c   Gay, S ^e   Kosmehl, H ^b  

^a Institute of Pathology   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d UNIVERSITY OF GENOA   (Italy)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Fibronectin; Osteoarthritis; Rheumatoid arthritis; Splice variants

Indexed keywords

FIBRONECTIN; ISOPROTEIN; MESSENGER RNA; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY LABELING; ANTIBODY SPECIFICITY; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; GLYCOSYLATION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; OSTEOARTHRITIS; PANNUS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIUM;

ALTERNATIVE SPLICING; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; FIBRONECTINS; HUMANS; IMMUNOHISTOCHEMISTRY; OSTEOARTHRITIS; PROTEIN ISOFORMS; RNA, MESSENGER; SYNOVIAL MEMBRANE;

EID: 10744224094     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-003-0316-1     Document Type: Article

References (63)

1. Kornblihtt AR, Pesce CG, Alonso CR, Cramer P, Srebrow A, Werbajh S, Muro AF (1996) The fibronectin gene as a model for splicing and transcription studies. FASEB J 10:248-257
2. Hynes RO (1985) Molecular biology of fibronectin. Ann Rev Cell Biol 1:67-90
3. Zardi L, Carnemolla B, Siri A, Petersen TE, Paolella G, Sebastio G, Baralle FE (1987) Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon. EMBO J 6:2337-2342
4. Koch GA, Schoen RC, Klebe RJ, Shows TB (1982) Assignment of a fibronectin gene to human chromosome 2 using monoclonal antibodies. Exp Cell Res 141:293-302
5. Vibe-Pedersen K, Kornblihtt AR, Baralle FE (1984) Expression of human alphaglobin/fibronectin gene hybrid generates two mRNAs by alternative splicing. EMBO J 3:2511-2526
6. Gutman A, Kornblihtt AR (1987) Identification of a third region of cell-specific alternative splicing in human fibronectin mRNA. Proc Natl Acad Sci U S A 84:7179-7182
7. Ffrench-Constant C, Van de Water L, Dvorak HF, Hynes RO (1989) Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. Cell Biol 109:903-914
8. Brown LF, Dubin D, Lavigne B, Logan B, Dvorak HF, Vandewater L (1993) Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing. Am J Pathol 142:793-801
9. Jarnagin WR, Rockey DC, Koteliansky VE, Wang S, Bissell DM (1994) Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. Cell Biol 127:2037-2048
10. Glukhova MA, Frid, MG, Shekhonin BV, Vasilevskaya TD, Grunwald J, Saginati M, Koteliansky VE (1989) Expression of extradomain A fibronectin sequence in vascular smooth muscle cells is phenotype dependent. Cell Biol 109:357-366
11. Ting KM, Rothaupt D, McCormick TS, Hammerberg C, Chen G, Gilliam AC, Stevens S, Culp L, Cooper KD (2000) Over-expression of the oncofetal Fn variant containing the EDA splice-in segment in the dermal-epidermal junction of psoriatic uninvolved skin. J Invest Dermatol 114:706-711
12. Scarpino S, Stoppacciaro A, Pellegrini C, Marzullo A, Zardi L, Tartaglia F, Viale G, Ruco LP (1999) Expression of EDA/EDB isoforms of fibronectin in papillary carcinoma of the thyroid. J Pathol 188:163-167
13. Kosmehl H, Berndt A, Strassburger S, Borsi L, Rousselle P, Mandel U, Hyckel P, Zardi L, Katenkamp D (1999) Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma. Br J Cancer 81: 1071-1079
14. Laitinen LM, Vartio T, Virtanen I (1991) Cellular fibronectins are differentially expressed in human fetal and adult kidney. Lab Invest 64:492-498
15. Schwarzbauer JE, Paul JI, Hynes RO (1985) On the origin of species of fibronectin. Proc Natl Acad Sci U S A 82:1424-1428
16. Mould AP, Wheldon LA, Komoriya A, Wayner EA, Yamada KM, Humphries MJ (1990) Affinity Chromatographic isolation of the melanoma adhesion receptor for the IIICS region of fibronectin and its identification as the integrin α4/β1. Biol Chem 265:4020-4024
17. Guan J-L, Hynes RO (1990) Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor α4/β1. Cell 60:53-61
18. Carnemolla B, Balza E, Siri A, Zardi L, Nicotra MR, Bigotti A, Natali PG (1989) A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. Cell Biol 108:1139-1148
19. Kaczmarek J, Castellani P, Nicolo G, Spina B, Allemanni G, Zardi L (1994) Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int J Cancer 58:11-16
20. Kosmehl H, Berndt A, Katenkamp D, Mandel U, Bohle R, Gabler U, Celeda D (1995) Differential expression of fibronectin splice variants, oncofetal glycosylated fibronectin and laminin isoforms in nodular palmar fibromatosis. Path Res Pract 191:1105-1113
21. Fassbender HG (1983) Histomorphological basis of articular cartilage destruction in rheumatoid arthritis. Coll Rel Res 3:141-155
22. Gay S, Denys FR, Tarkowski A, Gay RE, Tanaka A (1988) Ultrastructural demonstration of oncogene expression in proliferating synovial lining cells in rheumatoid arthritis. Arthritis Rheum 31:S23
23. Gay S, Gay RE, Koopman WJ (1993) Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Ann Rheum Dis 52:39-47
24. Matsuura H, Takio K, Titan K et al (1988) The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6. J Biol Chem 263:3314-3322
25. Borsi L, Carnemolla B, Castellani P, Rossellini C, Veccio D, Allemanni G, Chang SE, Taylor-Papadimitriou J, Pande H, Zardi L (1987) Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells. Cell Biol 104:595-600
26. Carnemolla B, Leprini A, Allemanni G, Saginati M, Zardi L (1992) The inclusion of the type III repeat ED-B in the fibronectin molecule generates conformational modifications that unmask a cryptic sequence. J Biol Chem 267: 24689-24692
27. Mandel U, Therkildsen MH, Reibel J, Gaggero B, Sweeney B, Matsuura H, Kakomori S-I, Dabelsteen E, Clausen H (1992) Cancer-associated changes in glycosylation of fibronectin. APMIS 100:817-826
28. Gustmann C, Altmannsberger M, Osborn M, Griesser H, Feller HC (1991) Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other non Hodgkin's lymphoma. Am J Pathol 138:1413-1422
29. Berndt A, Kosmehl H, Borsi L, Luo XM, Zardi L, Katenkamp D (1998) Evidence of ED-B fibronectin synthesis in human tissues by non-radioactive RNA in situ hybridization. Investigations on carcinoma (oral squamous cell and breast carcinoma), chronic inflammation (rheumatoid synovitis) and fibromatosis (Morbus Dupuytren). Histochem Cell Biol 109:249-255
30. Kriegsmann J, Keyszer G, Geiler T, Gay RE, Gay S (1994) A new double labeling technique for combined in situ hybridization and immunohistochemical analysis. Lab Invest 71:911-917
31. Scott DL, Delamere JP, Walton KW (1981) The distribution of fibronectin in the pannus of rheumatoid arthritis. Br J Exp Pathol 62:362-368
32. Scott DL, Wainwright AC, Walton KW, Williamson N (1981) Significance of fibronectin in rheumatoid arthritis and osteo-arthritis. Ann Rheum Dis 40:142-153
33. Cutolo M, Picasso M, Ponassi M, Sun MZ, Balza E (1992) Tenascin and fibronectin distribution in human normal and pathological synovium. J Rheumatol 19:1439-1447
34. Claudepierre P, Allanore Y, Belec L, Larget-Piet B, Zardi L, Chevalier X (1999) Increased Ed-B fibronectin plasma levels in spondyloarthropathies: comparison with rheumatoid arthritis patients and a healthy population. Rheumatology 38: 1099-1103
35. Shiozawa S, Ziff M (1983) Immunoelectron microscopic demonstration of fibronectin in rheumatoid pannus and at the cartilage-pannus junction. Ann Rheum Dis 42:254-263
36. Mapp PI, Revell PA (1985) Fibronectin production by synovial intimai cells. Rheumatol Int 5:229-237
37. Waller HA, Butler MG, McClean JGB, Dowd GSE, Scott DL (1992) Localisation of fibronectin mRNA in the rheumatoid synovium by in situ hybridisation. Ann Rheum Dis 51:735-740
38. Hino K, Shiozawa S, Kuroki Y, Ishikawa H, Shiozawa K, Sekiguchi K, Hirano H, Sakasihia E, Miyashita K, Chihara K (1995) EDA-containing fibronectin is synthesized from rheumatoid synovial fibroblast-like cells. Arthritis Rheum 38:678-683
39. Chevalier X, Claudepierre P, Groult N, Zardi L, Hornebeck W (1996) Presence of ED-A containing fibronectin in human articular cartilage from patients with osteoarthritis and rheumatoid arthritis. J Rheumatol 23:1022-1030
40. Shiozawa K, Hino K, Shiozawa S (2001) Alternatively spliced EDA-containing fibronectin in synovial fluid as a predictor of rheumatoid joint destruction. Rheumatology 40:739-742
41. Peters JH, Maunder RJ, Woolf AD, Cochrane CG, Ginsberg MH (1989) Elevated plasma levels of ED1+ ("cellular") fibronectin in patients with vascular injury. J Lab Clin Med 113:586-597
42. Carsons S, Clausen H, Wolf J (1994) Expression of a developmentally regulated epitope on fibronectins from the synovial fluid of patients with rheumatic disease. J Rheumatol 21: 1888-1891
43. Angel P, Karin M (1991) The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochem Biophys Acta 1072:129-157
44. Trabandt A, Gay RE, Gay S (1992) Oncogene activation in rheumatoid synovium. APMIS 100:861-875
45. Shiozawa S, Yoshihara R, Kuroki Y, Fujita T, Shiozawa K, Imura S (1992) Pathogenic importance of fibronectin in the superficial region of articular cartilage as a local factor for the induction of pannus extension on rheumatoid articular cartilage. Ann Rheum Dis 51:869-873
46. Müller-Ladner U, Kriegsmann J, Gay RE, Gay S (1995) Oncogenes in rheumatoid arthritis. Rheum Dis Clin North Am 21:675-690
47. Lalor PA, Mapp PI, Hall PA, Revell PA (1987) Proliferative activity of cells of the synovium as demonstrated by a monoclonal antibody, Ki-67. Rheumatol Int 7:183-186
48. Kinne RW, Emmrich F, Bail H, Kladny B, Schaser K, Stöss H, Mohr W (1995) Expression of activation markers of the rheumatoid arthritis synovial membrane: comment on the article by Qu et al. Arthritis Rheum 38:1346-1347
49. Mohr W, Beneke G, Mohring W (1975) Proliferation of synovial lining cells and fibroblasts. Ann Rheum Dis 34:217-224
50. Aicher WK, Heer AH, Trabandt A, Bridges SL Jr, Schroeder HW Jr, Stransky G, Gay RE, Bibel H, Peter HH, Siebenlist U, Koopman WJ, Gay S (1994) Overexpression of zinc-finger transcription factor Z-225/Egr-1 in synoviocytes from rheumatoid arthritis patients. J Immunol 152:5940-5948
51. Henderson B, Revell P, Edwards JCW (1988) Synovial lining hyperplasia in rheumatoid arthritis. Dogma and fact. Ann Rheum Dis 47:348-349
52. Ridley MG, Kingsley G, Pitzalis C, Panayi GS (1990) Monocyte activation in rheumatoid arthritis. Evidence for in situ activation and differentiation in joints. Br J Rheum 29:84-88
53. Kosmehl H, Berndt A, Katenkamp D (1996) Molecular variants of fibronectin and laminin: structure, physiological occurrence and histopathological aspects. Virchows Arch 429:311-322
54. Szekanecz Z, Haines GK, Harlow LA, Shah MR, Fong TW, Fu R, Lin SJ, Rayan G, Koch AE (1995) Increased synovial expression of transforming growth factor (TGF)-beta receptor endoglin and TGF-beta 1 in rheumatoid arthritis: possible interactions in the pathogenesis of the disease. Clin Immunol Immunopathol 76:187-194
55. Chu CQ, Field M, Allard S, Abney E, Feldmann M, Maini RN (1992) Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair. Br J Rheumatol 31:653-661
56. Sarkissian M, Lafyatis R (1998) Transforming growth factor-beta and platelet derived growth factor regulation of fibrillar fibronectin matrix formation by synovial fibroblasts. J Rheumatol 25:613-622
57. Berndt A, Kosmehl H, Mandel U, Gabler U, Luo X, Celeda D, Zardi L, Katenkamp D (1995) TGFβ and bFGF synthesis and localization in Dupuytren's Disease (nodular palmar fibromatosis) relative to cellular activity myofibroblast phenotype and oncofoetal variants of fibronectin. Histochem J 27:1014-1020
58. Walle TK, Vartio T, Helve T, Virtanen I, Kurki P (1990) Cellular fibronectin in rheumatoid synovium and synovial fluid: a possible factor contributing to lymphocytic infiltration. Scand J Immunol 31:535-540
59. Elices MJ, Tsai V, Strahl D, Goel AS, Tollefson V, Arrhenius T, Wayner EA, Gaeta FC, Fikes JD, Firestein GS (1994) Expression of functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature. J Clin Invest 93:405-416
60. Clemmensen I, Holund B, Andersen RB (1983) Fibrin and fibronectin in rheumatoid synovial membrane and rheumatoid synovial fluid. Arthritis Rheum 26:479-485
61. Müller-Ladner U, Elices MJ, Kriegsmann J, Strahl D, Gay RE, Firestein GS, Gay S (1997) Alternatively spliced CS-1 fibronectin isoform and its receptor VLA-4 in rheumatoid arthritis synovium. J Rheumatol 24: 1873-1880
62. Castellani P, Viale G, Dorcaratto A, Nicolo G, Kaczmarek J, Querze G, Zardi L (1994) The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Int J Cancer 59:612-618
63. Koch AE (1988) Angiogenesis. Implications for rheumatoid arthritis. Arthritis Rheum 41:951-962